APO Research
Talk to an analyst

APO RESEARCH · REPORT

Pan-cancer Genomic Profiling

Compare research editions
View pricing & licenses

Selected research

Industry Growth & Trends

Global Pan-cancer Genomic Profiling Industry Growth and Trends Forecast to 2032

12 August 2026114 pages

Choose your research edition.

Industry ResearchPan-cancer Genomic Profiling Industry Research Report 2026130 pages · $2,950 USDIndustry Growth & TrendsGlobal Pan-cancer Genomic Profiling Industry Growth and Trends Forecast to 2032114 pages · $3,450 USDMarket StructureGlobal Pan-cancer Genomic Profiling Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032198 pages · $3,950 USDMarket Outlook & Growth OpportunitiesGlobal Pan-cancer Genomic Profiling Market Outlook and Growth Opportunities 2026201 pages · $4,250 USDMarket Analysis & ForecastGlobal Pan-cancer Genomic Profiling Market Analysis and Forecast 2026-2032181 pages · $4,950 USD

Market perspective

According to APO Research, the global Pan-cancer Genomic Profiling market was valued at US$ million in 2026 and is projected to reach US$ million by 2032, implying a CAGR of xx% over 2026-2032.

The North America market for Pan-cancer Genomic Profiling is projected to increase from US$ million in 2026 to US$ million by 2032, corresponding to a CAGR of % over 2026-2032.

The Europe market for Pan-cancer Genomic Profiling is projected to increase from US$ million in 2026 to US$ million by 2032, registering a CAGR of % over 2026-2032.

Read the full market overview

The Asia Pacific market for Pan-cancer Genomic Profiling is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

Leading global companies in the Pan-cancer Genomic Profiling market include Tempus AI, Labcorp, NeoGenomics, Exact Sciences, Personalis, Illumina, Thermo Fisher Scientific, QIAGEN and Agilent Technologies, among others. In 2025, the top three vendors together accounted for approximately % of global revenue.

Report Scope

This report provides a structured, data-driven view of the global Pan-cancer Genomic Profiling market, combining harmonized quantitative metrics with targeted qualitative insight to support business and growth strategy, market positioning, and capital allocation.

The Pan-cancer Genomic Profiling market size, estimates, and forecasts are presented in terms of revenue (US$ million), with 2025 as the base year and historical and forecast data for 2021-2032. The report segments the global Pan-cancer Genomic Profiling market by Type, Application, region/country, and company, provides regional market sizes at the segment level, profiles the competitive landscape and key players and their market ranks, and reviews technology trends and new product developments relevant to Pan-cancer Genomic Profiling.

Key Companies & Market Share Insights

This section analyzes the strategies and performance of leading companies in the global Pan-cancer Genomic Profiling market, including portfolio focus, innovation and product development, mergers and acquisitions, collaborations, and geographic expansion used to sustain or enhance competitive positions. It also summarizes recent corporate developments and key financial indicators and provides global revenue and gross margin data by manufacturer for 2021-2026, enabling benchmarking of scale, profitability, and market share and supporting assessment of market concentration through indicators such as CR5 and CR10.

Pan-cancer Genomic Profiling Market by Company

Tempus AI

Labcorp

NeoGenomics

Exact Sciences

Personalis

Illumina

Thermo Fisher Scientific

QIAGEN

Agilent Technologies

SOPHiA GENETICS

Sysmex

Burning Rock Biotech

Genetron Health

Geneseeq

BGI Genomics

Amoy Diagnostics

Roche

Guardant Health

Caris Life Sciences

Pan-cancer Genomic Profiling Segment by Type

Tissue-based Profiling

Liquid Biopsy Profiling

Other

Pan-cancer Genomic Profiling Segment by Application

Hospitals and Cancer Centers

Independent Clinical Laboratories

Pharmaceutical and Biotechnology Companies

Other

Pan-cancer Genomic Profiling Segment by Region

North America

United States

Canada

Mexico

Europe

Germany

France

U.K.

Italy

Russia

Spain

Netherlands

Switzerland

Sweden

Poland

Asia-Pacific

China

Japan

South Korea

India

Australia

Taiwan

Southeast Asia

South America

Brazil

Argentina

Chile

Middle East & Africa

Egypt

South Africa

Israel

Türkiye

GCC Countries

Key Drivers & Barriers

High-impact rendering factors and drivers have been studied in this report to aid the readers to understand the general development. Moreover, the report includes restraints and challenges that may act as stumbling blocks on the way of the players. This will assist the users to be attentive and make informed decisions related to business. Specialists have also laid their focus on the upcoming business prospects.

Reasons to Buy This Report

1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Pan-cancer Genomic Profiling market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.

2. This report will help stakeholders to understand the global industry status and trends of Pan-cancer Genomic Profiling and provides them with information on key market drivers, restraints, challenges, and opportunities.

3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in value), competitor ecosystem, new product development, expansion, and acquisition.

4. This report stays updated with novel technology integration, features, and the latest developments in the market

5. This report helps stakeholders to gain insights into which regions to target globally

6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Pan-cancer Genomic Profiling.

7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.

Chapter Outline

Chapter 1: Introduces the report scope of the report, executive summary of global and regional market size and CAGR for the history and forecast period (2021-2025, 2026-2031). It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.

Chapter 2: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.

Chapter 3: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.

Chapter 4: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.

Chapter 5: Detailed analysis of Pan-cancer Genomic Profiling companies' competitive landscape, revenue, market share and ranking, latest development plan, merger, and acquisition information, etc.

Chapter 6: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product introduction, revenue, recent development, etc.

Chapter 7, 8, 9, 10 and 11: North America, Europe, Asia Pacific, South America, Middle East & Africa, revenue by country.

Chapter 12: Concluding Insights of the report

More report detail

Tables and figures
List of Tables Table 1. Global Pan-cancer Genomic Profiling Market Size (US$ Million) Comparison by Region: 2021 VS 2025 VS 2032 Table 2. Global Pan-cancer Genomic Profiling Market Size by Region (2021-2026) & (US$ Million) Table 3. Global Pan-cancer Genomic Profiling Market Share by Region (2021-2026) Table 4. Global Pan-cancer Genomic Profiling Market Size by Region (2027-2032) & (US$ Million) Table 5. Global Pan-cancer Genomic Profiling Market Share by Region (2027-2032) Table 6. Global Pan-cancer Genomic Profiling Market Size by Type (2021 VS 2025 VS 2032) & (US$ Million) Table 7. Global Pan-cancer Genomic Profiling Market Size by Type (2021-2026) & (US$ Million) Table 8. Global Pan-cancer Genomic Profiling Market Size Share by Type (2021-2026) Table 9. Global Pan-cancer Genomic Profiling Market Size Forecasted by Type (2027-2032) & (US$ Million) Table 10. Global Pan-cancer Genomic Profiling Market Size Share Forecasted by Type (2027-2032) Table 11. North America Pan-cancer Genomic Profiling Market Size Breakdown by Type (2021-2026) & (US$ Million) Table 12. North America Pan-cancer Genomic Profiling Market Size Breakdown by Type (2027-2032) & (US$ Million) Table 13. Europe Pan-cancer Genomic Profiling Market Size Breakdown by Type (2021-2026) & (US$ Million) Table 14. Europe Pan-cancer Genomic Profiling Market Size Breakdown by Type (2027-2032) & (US$ Million) Table 15. Asia-Pacific Pan-cancer Genomic Profiling Market Size Breakdown by Type (2021-2026) & (US$ Million) Table 16. Asia-Pacific Pan-cancer Genomic Profiling Market Size Breakdown by Type (2027-2032) & (US$ Million) Table 17. Latin America Pan-cancer Genomic Profiling Market Size Breakdown by Type (2021-2026) & (US$ Million) Table 18. Latin America Pan-cancer Genomic Profiling Market Size Breakdown by Type (2027-2032) & (US$ Million) Table 19. Middle East and Africa Pan-cancer Genomic Profiling Market Size Breakdown by Type (2021-2026) & (US$ Million) Table 20. Middle East and Africa Pan-cancer Genomic Profiling Market Size Breakdown by Type (2027-2032) & (US$ Million) Table 21. Global Pan-cancer Genomic Profiling Market Size by Application (2021 VS 2025 VS 2032) & (US$ Million) Table 22. Global Pan-cancer Genomic Profiling Market Size by Application (2021-2026) & (US$ Million) Table 23. Global Pan-cancer Genomic Profiling Market Size Share by Application (2021-2026) Table 24. Global Pan-cancer Genomic Profiling Market Size Forecasted by Application (2027-2032) & (US$ Million) Table 25. Global Pan-cancer Genomic Profiling Market Size Share Forecasted by Application (2027-2032) Table 26. North America Pan-cancer Genomic Profiling Market Size Breakdown by Application (2021-2026) & (US$ Million) Table 27. North America Pan-cancer Genomic Profiling Market Size Breakdown by Application (2027-2032) & (US$ Million) Table 28. Europe Pan-cancer Genomic Profiling Market Size Breakdown by Application (2021-2026) & (US$ Million) Table 29. Europe Pan-cancer Genomic Profiling Market Size Breakdown by Application (2027-2032) & (US$ Million) Table 30. Asia-Pacific Pan-cancer Genomic Profiling Market Size Breakdown by Application (2021-2026) & (US$ Million) Table 31. Asia-Pacific Pan-cancer Genomic Profiling Market Size Breakdown by Application (2027-2032) & (US$ Million) Table 32. Latin America Pan-cancer Genomic Profiling Market Size Breakdown by Application (2021-2026) & (US$ Million) Table 33. Latin America Pan-cancer Genomic Profiling Market Size Breakdown by Application (2027-2032) & (US$ Million) Table 34. Middle East and Africa Pan-cancer Genomic Profiling Market Size Breakdown by Application (2021-2026) & (US$ Million) Table 35. Middle East and Africa Pan-cancer Genomic Profiling Market Size Breakdown by Application (2027-2032) & (US$ Million) Table 36. Pan-cancer Genomic Profiling Industry Trends Table 37. Pan-cancer Genomic Profiling Industry Drivers Table 38. Pan-cancer Genomic Profiling Industry Opportunities and Challenges Table 39. Pan-cancer Genomic Profiling Industry Restraints Table 40. Global Pan-cancer Genomic Profiling Revenue by Company (US$ Million) & (2021-2026) Table 41. Global Pan-cancer Genomic Profiling Revenue Market Share by Company (2021-2026) Table 42. Global Pan-cancer Genomic Profiling Industry Company Ranking, 2024 VS 2025 VS 2026 Table 43. Global Pan-cancer Genomic Profiling Key Company Headquarters & Area Served Table 44. Global Pan-cancer Genomic Profiling Company, Product Type & Application Table 45. Global Pan-cancer Genomic Profiling Company Commercialization Time Table 46. Global Company Market Concentration Ratio (CR5 and HHI) Table 47. Global Pan-cancer Genomic Profiling by Company Type (Tier 1, Tier 2, and Tier 3) & (Based on the Revenue of 2025) Table 48. Tempus AI Company Information Table 49. Tempus AI Business Overview Table 50. Tempus AI Pan-cancer Genomic Profiling Revenue (US$ Million), Global Share (%) and Gross Margin (2021-2026) Table 51. Tempus AI Pan-cancer Genomic Profiling Product Portfolio Table 52. Tempus AI Recent Development Table 53. Labcorp Company Information Table 54. Labcorp Business Overview Table 55. Labcorp Pan-cancer Genomic Profiling Revenue (US$ Million), Global Share (%) and Gross Margin (2021-2026) Table 56. Labcorp Pan-cancer Genomic Profiling Product Portfolio Table 57. Labcorp Recent Development Table 58. NeoGenomics Company Information Table 59. NeoGenomics Business Overview Table 60. NeoGenomics Pan-cancer Genomic Profiling Revenue (US$ Million), Global Share (%) and Gross Margin (2021-2026) Table 61. NeoGenomics Pan-cancer Genomic Profiling Product Portfolio Table 62. NeoGenomics Recent Development Table 63. Exact Sciences Company Information Table 64. Exact Sciences Business Overview Table 65. Exact Sciences Pan-cancer Genomic Profiling Revenue (US$ Million), Global Share (%) and Gross Margin (2021-2026) Table 66. Exact Sciences Pan-cancer Genomic Profiling Product Portfolio Table 67. Exact Sciences Recent Development Table 68. Personalis Company Information Table 69. Personalis Business Overview Table 70. Personalis Pan-cancer Genomic Profiling Revenue (US$ Million), Global Share (%) and Gross Margin (2021-2026) Table 71. Personalis Pan-cancer Genomic Profiling Product Portfolio Table 72. Personalis Recent Development Table 73. Illumina Company Information Table 74. Illumina Business Overview Table 75. Illumina Pan-cancer Genomic Profiling Revenue (US$ Million), Global Share (%) and Gross Margin (2021-2026) Table 76. Illumina Pan-cancer Genomic Profiling Product Portfolio Table 77. Illumina Recent Development Table 78. Thermo Fisher Scientific Company Information Table 79. Thermo Fisher Scientific Business Overview Table 80. Thermo Fisher Scientific Pan-cancer Genomic Profiling Revenue (US$ Million), Global Share (%) and Gross Margin (2021-2026) Table 81. Thermo Fisher Scientific Pan-cancer Genomic Profiling Product Portfolio Table 82. Thermo Fisher Scientific Recent Development Table 83. QIAGEN Company Information Table 84. QIAGEN Business Overview Table 85. QIAGEN Pan-cancer Genomic Profiling Revenue (US$ Million), Global Share (%) and Gross Margin (2021-2026) Table 86. QIAGEN Pan-cancer Genomic Profiling Product Portfolio Table 87. QIAGEN Recent Development Table 88. Agilent Technologies Company Information Table 89. Agilent Technologies Business Overview Table 90. Agilent Technologies Pan-cancer Genomic Profiling Revenue (US$ Million), Global Share (%) and Gross Margin (2021-2026) Table 91. Agilent Technologies Pan-cancer Genomic Profiling Product Portfolio Table 92. Agilent Technologies Recent Development Table 93. SOPHiA GENETICS Company Information Table 94. SOPHiA GENETICS Business Overview Table 95. SOPHiA GENETICS Pan-cancer Genomic Profiling Revenue (US$ Million), Global Share (%) and Gross Margin (2021-2026) Table 96. SOPHiA GENETICS Pan-cancer Genomic Profiling Product Portfolio Table 97. SOPHiA GENETICS Recent Development Table 98. Sysmex Company Information Table 99. Sysmex Business Overview Table 100. Sysmex Pan-cancer Genomic Profiling Revenue (US$ Million), Global Share (%) and Gross Margin (2021-2026) Table 101. Sysmex Pan-cancer Genomic Profiling Product Portfolio Table 102. Sysmex Recent Development Table 103. Burning Rock Biotech Company Information Table 104. Burning Rock Biotech Business Overview Table 105. Burning Rock Biotech Pan-cancer Genomic Profiling Revenue (US$ Million), Global Share (%) and Gross Margin (2021-2026) Table 106. Burning Rock Biotech Pan-cancer Genomic Profiling Product Portfolio Table 107. Burning Rock Biotech Recent Development Table 108. Genetron Health Company Information Table 109. Genetron Health Business Overview Table 110. Genetron Health Pan-cancer Genomic Profiling Revenue (US$ Million), Global Share (%) and Gross Margin (2021-2026) Table 111. Genetron Health Pan-cancer Genomic Profiling Product Portfolio Table 112. Genetron Health Recent Development Table 113. Geneseeq Company Information Table 114. Geneseeq Business Overview Table 115. Geneseeq Pan-cancer Genomic Profiling Revenue (US$ Million), Global Share (%) and Gross Margin (2021-2026) Table 116. Geneseeq Pan-cancer Genomic Profiling Product Portfolio Table 117. Geneseeq Recent Development Table 118. BGI Genomics Company Information Table 119. BGI Genomics Business Overview Table 120. BGI Genomics Pan-cancer Genomic Profiling Revenue (US$ Million), Global Share (%) and Gross Margin (2021-2026) Table 121. BGI Genomics Pan-cancer Genomic Profiling Product Portfolio Table 122. BGI Genomics Recent Development Table 123. Amoy Diagnostics Company Information Table 124. Amoy Diagnostics Business Overview Table 125. Amoy Diagnostics Pan-cancer Genomic Profiling Revenue (US$ Million), Global Share (%) and Gross Margin (2021-2026) Table 126. Amoy Diagnostics Pan-cancer Genomic Profiling Product Portfolio Table 127. Amoy Diagnostics Recent Development Table 128. Roche Company Information Table 129. Roche Business Overview Table 130. Roche Pan-cancer Genomic Profiling Revenue (US$ Million), Global Share (%) and Gross Margin (2021-2026) Table 131. Roche Pan-cancer Genomic Profiling Product Portfolio Table 132. Roche Recent Development Table 133. Guardant Health Company Information Table 134. Guardant Health Business Overview Table 135. Guardant Health Pan-cancer Genomic Profiling Revenue (US$ Million), Global Share (%) and Gross Margin (2021-2026) Table 136. Guardant Health Pan-cancer Genomic Profiling Product Portfolio Table 137. Guardant Health Recent Development Table 138. Caris Life Sciences Company Information Table 139. Caris Life Sciences Business Overview Table 140. Caris Life Sciences Pan-cancer Genomic Profiling Revenue (US$ Million), Global Share (%) and Gross Margin (2021-2026) Table 141. Caris Life Sciences Pan-cancer Genomic Profiling Product Portfolio Table 142. Caris Life Sciences Recent Development Table 143. North America Pan-cancer Genomic Profiling Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 144. North America Pan-cancer Genomic Profiling Market Size by Country (2021-2026) & (US$ Million) Table 145. North America Pan-cancer Genomic Profiling Market Share by Country (2021-2026) Table 146. North America Pan-cancer Genomic Profiling Market Size Forecast by Country (2027-2032) & (US$ Million) Table 147. North America Pan-cancer Genomic Profiling Market Share Forecast by Country (2027-2032) Table 148. Europe Pan-cancer Genomic Profiling Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 149. Europe Pan-cancer Genomic Profiling Market Size by Country (2021-2026) & (US$ Million) Table 150. Europe Pan-cancer Genomic Profiling Market Share by Country (2021-2026) Table 151. Europe Pan-cancer Genomic Profiling Market Size Forecast by Country (2027-2032) & (US$ Million) Table 152. Europe Pan-cancer Genomic Profiling Market Share Forecast by Country (2027-2032) Table 153. Asia-Pacific Pan-cancer Genomic Profiling Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 154. Asia-Pacific Pan-cancer Genomic Profiling Market Size by Country (2021-2026) & (US$ Million) Table 155. Asia-Pacific Pan-cancer Genomic Profiling Market Share by Country (2021-2026) Table 156. Asia-Pacific Pan-cancer Genomic Profiling Market Size Forecast by Country (2027-2032) & (US$ Million) Table 157. Asia-Pacific Pan-cancer Genomic Profiling Market Share Forecast by Country (2027-2032) Table 158. Latin America Pan-cancer Genomic Profiling Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 159. Latin America Pan-cancer Genomic Profiling Market Size by Country (2021-2026) & (US$ Million) Table 160. Latin America Pan-cancer Genomic Profiling Market Share by Country (2021-2026) Table 161. Latin America Pan-cancer Genomic Profiling Market Size Forecast by Country (2027-2032) & (US$ Million) Table 162. Latin America Pan-cancer Genomic Profiling Market Share Forecast by Country (2027-2032) Table 163. Middle East & Africa Pan-cancer Genomic Profiling Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 164. Middle East & Africa Pan-cancer Genomic Profiling Market Size by Country (2021-2026) & (US$ Million) Table 165. Middle East & Africa Pan-cancer Genomic Profiling Market Share by Country (2021-2026) Table 166. Middle East & Africa Pan-cancer Genomic Profiling Market Size Forecast by Country (2027-2032) & (US$ Million) Table 167. Middle East & Africa Pan-cancer Genomic Profiling Market Share Forecast by Country (2027-2032) Table 168. Research Programs/Design for This Report Table 169. Authors List of This Report Table 170. Secondary Sources List of Figures Figure 1.List of Figures Figure 2. Pan-cancer Genomic Profiling Product Image Figure 3. Global Pan-cancer Genomic Profiling Market Size (US$ Million), 2021 VS 2025 VS 2032 Figure 4. Global Pan-cancer Genomic Profiling Market Size (2021-2032) & (US$ Million) Figure 5. Global Pan-cancer Genomic Profiling Market Share by Region: 2025 VS 2032 Figure 6. Global Pan-cancer Genomic Profiling Market Share by Region (2021-2032) Figure 7. North America Pan-cancer Genomic Profiling Market Size Growth Rate (2021-2032) & (US$ Million) Figure 8. Europe Pan-cancer Genomic Profiling Market Size Growth Rate (2021-2032) & (US$ Million) Figure 9. Asia-Pacific Pan-cancer Genomic Profiling Market Size Growth Rate (2021-2032) & (US$ Million) Figure 10. Latin America Pan-cancer Genomic Profiling Market Size Growth Rate (2021-2032) & (US$ Million) Figure 11. Middle East & Africa Pan-cancer Genomic Profiling Market Size Growth Rate (2021-2032) & (US$ Million) Figure 12. Tissue-based Profiling Image Figure 13. Global Tissue-based Profiling Market Size YoY Growth (2021-2032) & (US$ Million) Figure 14. Liquid Biopsy Profiling Image Figure 15. Global Liquid Biopsy Profiling Market Size YoY Growth (2021-2032) & (US$ Million) Figure 16. Other Image Figure 17. Global Other Market Size YoY Growth (2021-2032) & (US$ Million) Figure 18. Global Pan-cancer Genomic Profiling Market Size Overview by Type (2021-2032) & (US$ Million) Figure 19. Global Pan-cancer Genomic Profiling Market Share by Type 2025 VS 2032 Figure 20. North America Pan-cancer Genomic Profiling Market Size Share by Type (2021-2032) Figure 21. Europe Pan-cancer Genomic Profiling Market Size Share by Type (2021-2032) Figure 22. Asia-Pacific Pan-cancer Genomic Profiling Market Size Share by Type (2021-2032) Figure 23. Latin America Pan-cancer Genomic Profiling Market Size Share by Type (2021-2032) Figure 24. Middle East and Africa Pan-cancer Genomic Profiling Market Size Share by Type (2021-2032) Figure 25. Hospitals and Cancer Centers Image Figure 26. Global Hospitals and Cancer Centers Market Size YoY Growth (2021-2032) & (US$ Million) Figure 27. Independent Clinical Laboratories Image Figure 28. Global Independent Clinical Laboratories Market Size YoY Growth (2021-2032) & (US$ Million) Figure 29. Pharmaceutical and Biotechnology Companies Image Figure 30. Global Pharmaceutical and Biotechnology Companies Market Size YoY Growth (2021-2032) & (US$ Million) Figure 31. Other Image Figure 32. Global Other Market Size YoY Growth (2021-2032) & (US$ Million) Figure 33. Global Pan-cancer Genomic Profiling Market Size Overview by Application (2021-2032) & (US$ Million) Figure 34. Global Pan-cancer Genomic Profiling Market Share by Application 2025 VS 2032 Figure 35. North America Pan-cancer Genomic Profiling Market Size Share by Application (2021-2032) Figure 36. Europe Pan-cancer Genomic Profiling Market Size Share by Application (2021-2032) Figure 37. Asia-Pacific Pan-cancer Genomic Profiling Market Size Share by Application (2021-2032) Figure 38. Latin America Pan-cancer Genomic Profiling Market Size Share by Application (2021-2032) Figure 39. Middle East and Africa Pan-cancer Genomic Profiling Market Size Share by Application (2021-2032) Figure 40. Global Top 5 and 10 Pan-cancer Genomic Profiling Players Market Share by Revenue in 2025 Figure 41. Company Type (Tier 1, Tier 2, and Tier 3): 2021 VS 2025 Figure 42. North America Pan-cancer Genomic Profiling Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 43. North America Pan-cancer Genomic Profiling Market Share by Country: 2021 VS 2025 VS 2032 Figure 44. North America Pan-cancer Genomic Profiling Market Share by Country (2021-2032) Figure 45. Europe Pan-cancer Genomic Profiling Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 46. Europe Pan-cancer Genomic Profiling Market Share by Country: 2021 VS 2025 VS 2032 Figure 47. Europe Pan-cancer Genomic Profiling Market Share by Country (2021-2032) Figure 48. Asia-Pacific Pan-cancer Genomic Profiling Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 49. Asia-Pacific Pan-cancer Genomic Profiling Market Share by Country: 2021 VS 2025 VS 2032 Figure 50. Asia-Pacific Pan-cancer Genomic Profiling Market Share by Country (2021-2032) Figure 51. Latin America Pan-cancer Genomic Profiling Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 52. Latin America Pan-cancer Genomic Profiling Market Share by Country: 2021 VS 2025 VS 2032 Figure 53. Latin America Pan-cancer Genomic Profiling Market Share by Country (2021-2032) Figure 54. Middle East & Africa Pan-cancer Genomic Profiling Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 55. Middle East & Africa Pan-cancer Genomic Profiling Market Share by Country: 2021 VS 2025 VS 2032 Figure 56. Middle East & Africa Pan-cancer Genomic Profiling Market Share by Country (2021-2032) Figure 57. Years Considered Figure 58. Research Process Figure 59. Key Executives Interviewed

Scope & coverage.

Types
  • Tissue-based Profiling
  • Liquid Biopsy Profiling
  • Other
Applications
  • Hospitals and Cancer Centers
  • Independent Clinical Laboratories
  • Pharmaceutical and Biotechnology Companies
  • Other
Companies covered
  • Tempus AI
  • Labcorp
  • NeoGenomics
  • Exact Sciences
  • Personalis
  • Illumina
  • Thermo Fisher Scientific
  • QIAGEN
  • Agilent Technologies
  • SOPHiA GENETICS
  • Sysmex
  • Burning Rock Biotech
  • Genetron Health
  • Geneseeq
  • BGI Genomics
  • Amoy Diagnostics
  • Roche
  • Guardant Health
  • Caris Life Sciences

Inside the report.

1 Market Overview
  1. 1.1 Product Definition
  2. 1.2 Global Market Growth Prospects
  3. 1.3 Global Pan-cancer Genomic Profiling Market Size Overview by Region 2021 VS 2025 VS 2032
  4. 1.4 Global Pan-cancer Genomic Profiling Market Size by Region (2021-2032)
  5. 1.4.1 Global Pan-cancer Genomic Profiling Market Size by Region (2021-2026)
  6. 1.4.2 Global Pan-cancer Genomic Profiling Market Size by Region (2027-2032)
  7. 1.5 Key Regions Pan-cancer Genomic Profiling Market Size (2021-2032)
  8. 1.5.1 North America Pan-cancer Genomic Profiling Market Size Growth Rate (2021-2032)
  9. 1.5.2 Europe Pan-cancer Genomic Profiling Market Size Growth Rate (2021-2032)
  10. 1.5.3 Asia-Pacific Pan-cancer Genomic Profiling Market Size Growth Rate (2021-2032)
  11. 1.5.4 South America Pan-cancer Genomic Profiling Market Size Growth Rate (2021-2032)
  12. 1.5.5 Middle East & Africa Pan-cancer Genomic Profiling Market Size Growth Rate (2021-2032)
2 Pan-cancer Genomic Profiling Market by Type
  1. 2.1 Type Introduction
  2. 2.1.1 Tissue-based Profiling
  3. 2.1.2 Liquid Biopsy Profiling
  4. 2.1.3 Other
  5. 2.2 Global Pan-cancer Genomic Profiling Market Size by Type
  6. 2.2.1 Global Pan-cancer Genomic Profiling Market Size Overview by Type (2021-2032)
  7. 2.2.2 Global Pan-cancer Genomic Profiling Historic Market Size Review by Type (2021-2026)
  8. 2.2.3 Global Pan-cancer Genomic Profiling Market Size Forecasted by Type (2027-2032)
  9. 2.3 Global Pan-cancer Genomic Profiling Market Size by Regions
  10. 2.3.1 North America Pan-cancer Genomic Profiling Market Size Breakdown by Type (2021-2026)
  11. 2.3.2 Europe Pan-cancer Genomic Profiling Market Size Breakdown by Type (2021-2026)
  12. 2.3.3 Asia-Pacific Pan-cancer Genomic Profiling Market Size Breakdown by Type (2021-2026)
  13. 2.3.4 South America Pan-cancer Genomic Profiling Market Size Breakdown by Type (2021-2026)
  14. 2.3.5 Middle East and Africa Pan-cancer Genomic Profiling Market Size Breakdown by Type (2021-2026)
3 Pan-cancer Genomic Profiling Market by Application
  1. 3.1 Type Introduction
  2. 3.1.1 Hospitals and Cancer Centers
  3. 3.1.2 Independent Clinical Laboratories
  4. 3.1.3 Pharmaceutical and Biotechnology Companies
  5. 3.1.4 Other
  6. 3.2 Global Pan-cancer Genomic Profiling Market Size by Application
  7. 3.2.1 Global Pan-cancer Genomic Profiling Market Size Overview by Application (2021-2032)
  8. 3.2.2 Global Pan-cancer Genomic Profiling Historic Market Size Review by Application (2021-2026)
  9. 3.2.3 Global Pan-cancer Genomic Profiling Market Size Forecasted by Application (2027-2032)
  10. 3.3 Global Pan-cancer Genomic Profiling Market Size by Regions
  11. 3.3.1 North America Pan-cancer Genomic Profiling Market Size Breakdown by Application (2021-2026)
  12. 3.3.2 Europe Pan-cancer Genomic Profiling Market Size Breakdown by Application (2021-2026)
  13. 3.3.3 Asia-Pacific Pan-cancer Genomic Profiling Market Size Breakdown by Application (2021-2026)
  14. 3.3.4 South America Pan-cancer Genomic Profiling Market Size Breakdown by Application (2021-2026)
  15. 3.3.5 Middle East and Africa Pan-cancer Genomic Profiling Market Size Breakdown by Application (2021-2026)
4 Global Market Dynamics
  1. 4.1 Pan-cancer Genomic Profiling Industry Trends
  2. 4.2 Pan-cancer Genomic Profiling Industry Drivers
  3. 4.3 Pan-cancer Genomic Profiling Industry Opportunities and Challenges
  4. 4.4 Pan-cancer Genomic Profiling Industry Restraints
5 Competitive Insights by Company
  1. 5.1 Global Top Players by Pan-cancer Genomic Profiling Revenue (2021-2026)
  2. 5.2 Global Pan-cancer Genomic Profiling Industry Company Ranking, 2024 VS 2025 VS 2026
  3. 5.3 Global Pan-cancer Genomic Profiling Key Company Headquarters & Area Served
  4. 5.4 Global Pan-cancer Genomic Profiling Company, Product Type & Application
  5. 5.5 Global Pan-cancer Genomic Profiling Company Commercialization Time
  6. 5.6 Market Competitive Analysis
  7. 5.6.1 Global Pan-cancer Genomic Profiling Market CR5 and HHI
  8. 5.6.2 Global Top 5 and 10 Pan-cancer Genomic Profiling Players Market Share by Revenue in 2025
  9. 5.6.3 2025 Pan-cancer Genomic Profiling Tier 1, Tier 2, and Tier 3
6 Company Profiles
  1. 6.1 Tempus AI
  2. 6.1.1 Tempus AI Company Information
  3. 6.1.2 Tempus AI Business Overview
  4. 6.1.3 Tempus AI Pan-cancer Genomic Profiling Revenue, Global Share and Gross Margin (2021-2026)
  5. 6.1.4 Tempus AI Pan-cancer Genomic Profiling Product Portfolio
  6. 6.1.5 Tempus AI Recent Developments
  7. 6.2 Labcorp
  8. 6.2.1 Labcorp Company Information
  9. 6.2.2 Labcorp Business Overview
  10. 6.2.3 Labcorp Pan-cancer Genomic Profiling Revenue, Global Share and Gross Margin (2021-2026)
  11. 6.2.4 Labcorp Pan-cancer Genomic Profiling Product Portfolio
  12. 6.2.5 Labcorp Recent Developments
  13. 6.3 NeoGenomics
  14. 6.3.1 NeoGenomics Company Information
  15. 6.3.2 NeoGenomics Business Overview
  16. 6.3.3 NeoGenomics Pan-cancer Genomic Profiling Revenue, Global Share and Gross Margin (2021-2026)
  17. 6.3.4 NeoGenomics Pan-cancer Genomic Profiling Product Portfolio
  18. 6.3.5 NeoGenomics Recent Developments
  19. 6.4 Exact Sciences
  20. 6.4.1 Exact Sciences Company Information
  21. 6.4.2 Exact Sciences Business Overview
  22. 6.4.3 Exact Sciences Pan-cancer Genomic Profiling Revenue, Global Share and Gross Margin (2021-2026)
  23. 6.4.4 Exact Sciences Pan-cancer Genomic Profiling Product Portfolio
  24. 6.4.5 Exact Sciences Recent Developments
  25. 6.5 Personalis
  26. 6.5.1 Personalis Company Information
  27. 6.5.2 Personalis Business Overview
  28. 6.5.3 Personalis Pan-cancer Genomic Profiling Revenue, Global Share and Gross Margin (2021-2026)
  29. 6.5.4 Personalis Pan-cancer Genomic Profiling Product Portfolio
  30. 6.5.5 Personalis Recent Developments
  31. 6.6 Illumina
  32. 6.6.1 Illumina Company Information
  33. 6.6.2 Illumina Business Overview
  34. 6.6.3 Illumina Pan-cancer Genomic Profiling Revenue, Global Share and Gross Margin (2021-2026)
  35. 6.6.4 Illumina Pan-cancer Genomic Profiling Product Portfolio
  36. 6.6.5 Illumina Recent Developments
  37. 6.7 Thermo Fisher Scientific
  38. 6.7.1 Thermo Fisher Scientific Company Information
  39. 6.7.2 Thermo Fisher Scientific Business Overview
  40. 6.7.3 Thermo Fisher Scientific Pan-cancer Genomic Profiling Revenue, Global Share and Gross Margin (2021-2026)
  41. 6.7.4 Thermo Fisher Scientific Pan-cancer Genomic Profiling Product Portfolio
  42. 6.7.5 Thermo Fisher Scientific Recent Developments
  43. 6.8 QIAGEN
  44. 6.8.1 QIAGEN Company Information
  45. 6.8.2 QIAGEN Business Overview
  46. 6.8.3 QIAGEN Pan-cancer Genomic Profiling Revenue, Global Share and Gross Margin (2021-2026)
  47. 6.8.4 QIAGEN Pan-cancer Genomic Profiling Product Portfolio
  48. 6.8.5 QIAGEN Recent Developments
  49. 6.9 Agilent Technologies
  50. 6.9.1 Agilent Technologies Company Information
  51. 6.9.2 Agilent Technologies Business Overview
  52. 6.9.3 Agilent Technologies Pan-cancer Genomic Profiling Revenue, Global Share and Gross Margin (2021-2026)
  53. 6.9.4 Agilent Technologies Pan-cancer Genomic Profiling Product Portfolio
  54. 6.9.5 Agilent Technologies Recent Developments
  55. 6.10 SOPHiA GENETICS
  56. 6.10.1 SOPHiA GENETICS Company Information
  57. 6.10.2 SOPHiA GENETICS Business Overview
  58. 6.10.3 SOPHiA GENETICS Pan-cancer Genomic Profiling Revenue, Global Share and Gross Margin (2021-2026)
  59. 6.10.4 SOPHiA GENETICS Pan-cancer Genomic Profiling Product Portfolio
  60. 6.10.5 SOPHiA GENETICS Recent Developments
  61. 6.11 Sysmex
  62. 6.11.1 Sysmex Company Information
  63. 6.11.2 Sysmex Business Overview
  64. 6.11.3 Sysmex Pan-cancer Genomic Profiling Revenue, Global Share and Gross Margin (2021-2026)
  65. 6.11.4 Sysmex Pan-cancer Genomic Profiling Product Portfolio
  66. 6.11.5 Sysmex Recent Developments
  67. 6.12 Burning Rock Biotech
  68. 6.12.1 Burning Rock Biotech Company Information
  69. 6.12.2 Burning Rock Biotech Business Overview
  70. 6.12.3 Burning Rock Biotech Pan-cancer Genomic Profiling Revenue, Global Share and Gross Margin (2021-2026)
  71. 6.12.4 Burning Rock Biotech Pan-cancer Genomic Profiling Product Portfolio
  72. 6.12.5 Burning Rock Biotech Recent Developments
  73. 6.13 Genetron Health
  74. 6.13.1 Genetron Health Company Information
  75. 6.13.2 Genetron Health Business Overview
  76. 6.13.3 Genetron Health Pan-cancer Genomic Profiling Revenue, Global Share and Gross Margin (2021-2026)
  77. 6.13.4 Genetron Health Pan-cancer Genomic Profiling Product Portfolio
  78. 6.13.5 Genetron Health Recent Developments
  79. 6.14 Geneseeq
  80. 6.14.1 Geneseeq Company Information
  81. 6.14.2 Geneseeq Business Overview
  82. 6.14.3 Geneseeq Pan-cancer Genomic Profiling Revenue, Global Share and Gross Margin (2021-2026)
  83. 6.14.4 Geneseeq Pan-cancer Genomic Profiling Product Portfolio
  84. 6.14.5 Geneseeq Recent Developments
  85. 6.15 BGI Genomics
  86. 6.15.1 BGI Genomics Company Information
  87. 6.15.2 BGI Genomics Business Overview
  88. 6.15.3 BGI Genomics Pan-cancer Genomic Profiling Revenue, Global Share and Gross Margin (2021-2026)
  89. 6.15.4 BGI Genomics Pan-cancer Genomic Profiling Product Portfolio
  90. 6.15.5 BGI Genomics Recent Developments
  91. 6.16 Amoy Diagnostics
  92. 6.16.1 Amoy Diagnostics Company Information
  93. 6.16.2 Amoy Diagnostics Business Overview
  94. 6.16.3 Amoy Diagnostics Pan-cancer Genomic Profiling Revenue, Global Share and Gross Margin (2021-2026)
  95. 6.16.4 Amoy Diagnostics Pan-cancer Genomic Profiling Product Portfolio
  96. 6.16.5 Amoy Diagnostics Recent Developments
  97. 6.17 Roche
  98. 6.17.1 Roche Company Information
  99. 6.17.2 Roche Business Overview
  100. 6.17.3 Roche Pan-cancer Genomic Profiling Revenue, Global Share and Gross Margin (2021-2026)
  101. 6.17.4 Roche Pan-cancer Genomic Profiling Product Portfolio
  102. 6.17.5 Roche Recent Developments
  103. 6.18 Guardant Health
  104. 6.18.1 Guardant Health Company Information
  105. 6.18.2 Guardant Health Business Overview
  106. 6.18.3 Guardant Health Pan-cancer Genomic Profiling Revenue, Global Share and Gross Margin (2021-2026)
  107. 6.18.4 Guardant Health Pan-cancer Genomic Profiling Product Portfolio
  108. 6.18.5 Guardant Health Recent Developments
  109. 6.19 Caris Life Sciences
  110. 6.19.1 Caris Life Sciences Company Information
  111. 6.19.2 Caris Life Sciences Business Overview
  112. 6.19.3 Caris Life Sciences Pan-cancer Genomic Profiling Revenue, Global Share and Gross Margin (2021-2026)
  113. 6.19.4 Caris Life Sciences Pan-cancer Genomic Profiling Product Portfolio
  114. 6.19.5 Caris Life Sciences Recent Developments
7 North America
  1. 7.1 North America Pan-cancer Genomic Profiling Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  2. 7.2 North America Pan-cancer Genomic Profiling Market Size by Country (2021-2026)
  3. 7.3 North America Pan-cancer Genomic Profiling Market Size Forecast by Country (2027-2032)
8 Europe
  1. 8.1 Europe Pan-cancer Genomic Profiling Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  2. 8.2 Europe Pan-cancer Genomic Profiling Market Size by Country (2021-2026)
  3. 8.3 Europe Pan-cancer Genomic Profiling Market Size Forecast by Country (2027-2032)
9 Asia-Pacific
  1. 9.1 Asia-Pacific Pan-cancer Genomic Profiling Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  2. 9.2 Asia-Pacific Pan-cancer Genomic Profiling Market Size by Country (2021-2026)
  3. 9.3 Asia-Pacific Pan-cancer Genomic Profiling Market Size Forecast by Country (2027-2032)
10 South America
  1. 10.1 South America Pan-cancer Genomic Profiling Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  2. 10.2 South America Pan-cancer Genomic Profiling Market Size by Country (2021-2026)
  3. 10.3 South America Pan-cancer Genomic Profiling Market Size Forecast by Country (2027-2032)
11 Middle East & Africa
  1. 11.1 Middle East & Africa Pan-cancer Genomic Profiling Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  2. 11.2 Middle East & Africa Pan-cancer Genomic Profiling Market Size by Country (2021-2026)
  3. 11.3 Middle East & Africa Pan-cancer Genomic Profiling Market Size Forecast by Country (2027-2032)
12 Concluding Insights
    13 Appendix
    1. 13.1 Reasons for Doing This Study
    2. 13.2 Research Methodology
    3. 13.3 Research Process
    4. 13.4 Authors List of This Report
    5. 13.5 Data Source
    6. 13.5.1 Secondary Sources
    7. 13.5.2 Primary Sources

    GET THE RESEARCH

    Choose your license.

    Choose who needs access.
    All options are for this report and research series.

    Compare access permissions.

    Single User License
    One named user. Individual access.
    Multi User License
    Up to 5 users in the same department.
    Enterprise License
    Organization-wide access within the agreed license.

    Access applies to the purchased edition. Later editions are separate purchases.

    License options
    $3,450USD
    Buy now

    PDF by email within 3–5 working days after payment confirmation.

    Talk to an analyst
    APO Research
    Talk to an analyst